| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.41 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.35 | 0.02 |